DARPA’s Biological Technologies Office is seeking innovative proposals in relation to specific topics in the following areas:
- biological technology topic areas that fit the national security scope of BTO’s mission.
- research into market opportunities, constraints, and communities affecting financing and
commercialization of bioindustrial and biomedical technologies. - machine learning and AI – eg models, technologies, virtual testbeds, digital twins, non-experimental models
- human performance – eg treatment and resilience in neurological health and cognitive function, interventions for assessment and optimisation; continuous physiology monitoring, human-machine interfaces
- materials, sensors and processing – eg novel materials, sensors or processes, foundation models or prediction engines, engineering of biological systems, platform technologies, hybrid biological/engineered systems, remote sensing, biological sensor platforms
- ecosystem and environmental – eg countermeasures to global food and water supplies, concealment and camouflage, leveraging synthetic biology, ecosystem restoration
- biosecurity and biosafety – eg characterising emerging pathogens, infectious disease treatment, prevention, forecasting, detection,
- biomedical and biodefense – eg causal relationships underlying acute and chronic diseases, critical molecule, next-gen cellular therapeutics, platform technologies, diagnostics, prophylactic and therapeutic approaches
Abstracts (encouraged but not compulsory) and proposals will be accepted and assessed on a rolling basis until 10 September 2025.
Document
Broad Agency Announcement – Biological Technologies: HR001124S0034
